IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 98 filers reported holding IGM BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $265,964 | -41.0% | 31,852 | -34.8% | 0.00% | – |
Q2 2023 | $450,923 | +123.6% | 48,854 | +232.9% | 0.00% | – |
Q1 2023 | $201,635 | -71.1% | 14,675 | -64.3% | 0.00% | – |
Q4 2022 | $698,584 | -38.9% | 41,069 | -18.3% | 0.00% | – |
Q3 2022 | $1,143,000 | +67.1% | 50,274 | +32.4% | 0.00% | – |
Q2 2022 | $684,000 | -87.7% | 37,984 | -81.7% | 0.00% | – |
Q1 2022 | $5,555,000 | +1957.4% | 207,832 | +2159.0% | 0.00% | – |
Q4 2021 | $270,000 | -95.6% | 9,200 | -90.2% | 0.00% | -100.0% |
Q3 2021 | $6,155,000 | +348.6% | 93,600 | +467.3% | 0.00% | – |
Q2 2021 | $1,372,000 | -79.1% | 16,500 | -80.7% | 0.00% | -100.0% |
Q1 2021 | $6,573,000 | -34.7% | 85,714 | -24.9% | 0.00% | -66.7% |
Q4 2020 | $10,070,000 | +167.5% | 114,059 | +123.7% | 0.00% | +200.0% |
Q3 2020 | $3,764,000 | +126.1% | 50,987 | +123.5% | 0.00% | 0.0% |
Q2 2020 | $1,665,000 | +41.7% | 22,809 | +9.0% | 0.00% | 0.0% |
Q1 2020 | $1,175,000 | +124.2% | 20,918 | +52.4% | 0.00% | – |
Q4 2019 | $524,000 | -41.1% | 13,726 | -72.6% | 0.00% | – |
Q3 2019 | $890,000 | – | 50,094 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,425,455 | $225,258,000 | 3.93% |
Artal Group S.A. | 1,350,000 | $88,776,000 | 1.99% |
Eagle Bay Advisors LLC | 35,295 | $2,321,000 | 1.30% |
Cormorant Asset Management, LP | 350,000 | $23,016,000 | 0.94% |
Baker Brothers Advisors | 3,156,102 | $207,545,000 | 0.91% |
Bruce & Co., Inc. | 55,000 | $3,616,000 | 0.77% |
Altium Capital Management LP | 42,473 | $2,793,000 | 0.73% |
HighVista Strategies LLC | 15,446 | $1,016,000 | 0.67% |
Woodline Partners LP | 569,009 | $37,418,000 | 0.61% |
Ikarian Capital, LLC | 100,000 | $6,576,000 | 0.46% |